Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically S
about
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically S
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study to Evaluate Switching Fr ...... let Regimen in Virologically S
@en
type
label
Study to Evaluate Switching Fr ...... let Regimen in Virologically S
@en
prefLabel
Study to Evaluate Switching Fr ...... let Regimen in Virologically S
@en
P17
P4844
P6153
P131
P1476
A Phase 3b Randomized, Open-La ...... essed, HIV-1 Infected Patients
@en
P17
P3098
NCT01475838
P580
2011-11-01T00:00:00Z
P582
2013-11-01T00:00:00Z